Jim Cramer Calls Butterfly Network “Too Hard” After GE Healthcare Rally Faded
Jim Cramer said Butterfly Network’s handheld ultrasound business faces intense competition and declined to back the stock after noting GE Healthcare’s strong report failed to sustain gains. He labeled the segment “too hard” and expressed reluctance to invest in this part of the medical device group.
1. Cramer’s Commentary
Jim Cramer reviewed Butterfly Network’s handheld ultrasound devices and cited intense competition in the medical device sector. He contrasted GE Healthcare’s brief rally—where shares rose but quickly reversed—with Butterfly’s market challenges, concluding the space was “too hard” for his investment style.
2. Competitive Landscape
Butterfly Network competes by offering whole-body imaging via a single probe linked to smartphones and computers, targeting a $45 billion ultrasound market. Established rivals like GE Healthcare and Philips maintain strong market share and drive rapid technological advances, increasing pressure on newer entrants like Butterfly Network.